A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
about
Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testingN348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistanceA polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activityHuman immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.The "Connection" Between HIV Drug Resistance and RNase HThe recombinant maize ribosome-inactivating protein transiently reduces viral load in SHIV89.6 infected Chinese Rhesus Macaques.Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimensAmino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitorsHIV-1 drug resistance mutations: an updated framework for the second decade of HAARTNonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South AfricaConnection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments.Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antAn in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1.
P2860
Q28471687-E13B29C6-73A4-49BC-A848-15B646402382Q28471689-14BB7307-2B1C-49DA-B9D9-A69F7CAD3B18Q28533996-592E2C2A-EF33-445C-BAF0-0C8ACEB80C99Q33987492-04B1C2FD-6F65-401A-86B3-C6011F0604D1Q34313605-4651B6DB-F563-4F2C-BFCC-15E3A99447B5Q35003689-584D1007-D141-4A56-B2D3-E169243280CDQ35004847-597CC157-A2EE-42A4-9D01-7531EDD952DDQ36498272-216F3A21-0429-4424-BE91-A9913D391399Q36900010-79DF0FD1-26C5-471B-B8D2-B6D6D23FDEF6Q37409842-B1A41012-33AC-40A4-B7EA-5CF1CAD6389BQ37613017-9680C04F-29B6-47D3-BB8B-C997B0489048Q41262484-34B9B46C-1F79-4D1A-9106-87DE5E0ADB5AQ42033549-F89B962B-2865-4D85-8890-16E04277B95BQ42148219-7631D63A-6815-4732-87AF-4705638085B3Q50975515-06E7D4CF-6021-4368-A66A-64B9BD384AEC
P2860
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A mutation in the 3' region of ...... criptase inhibitor resistance.
@en
A mutation in the 3' region of ...... s type 1 reverse transcriptase
@nl
type
label
A mutation in the 3' region of ...... criptase inhibitor resistance.
@en
A mutation in the 3' region of ...... s type 1 reverse transcriptase
@nl
prefLabel
A mutation in the 3' region of ...... criptase inhibitor resistance.
@en
A mutation in the 3' region of ...... s type 1 reverse transcriptase
@nl
P2093
P2860
P1433
P1476
A mutation in the 3' region of ...... criptase inhibitor resistance.
@en
P2093
Brendan Larder
Brian Wynhoven
David K Stammers
Mahboob Salim
P Richard Harrigan
Paula McKenna
P2860
P304
P356
10.1128/JVI.76.13.6836-6840.2002
P407
P577
2002-07-01T00:00:00Z